483
Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd. – FDA 483, Jun 17, 2025
Record Details
An FDA inspection of Otsuka Pharmaceutical Co., Ltd. in Naka-Gun, Tokushima, Japan, a sterile drug product manufacturer, revealed significant deficiencies. The firm failed to establish adequate written procedures for production and process controls, particularly concerning aseptic processing validation and environmental monitoring. Additionally, laboratory controls for growth promotion testing were found to be deficient.
View Company Profile
ID · 500e2ebb-23c6-432a-a86f-6865269ae086
Other documents for Otsuka Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.